Sumitomo Mitsui Trust Group Inc. Boosts Stake in Sabra Healthcare REIT, Inc. $SBRA

Sumitomo Mitsui Trust Group Inc. boosted its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 6.8% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,208,600 shares of the real estate investment trust’s stock after buying an additional 203,226 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Sabra Healthcare REIT were worth $61,701,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in SBRA. Principal Financial Group Inc. raised its holdings in shares of Sabra Healthcare REIT by 21.6% during the 4th quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock worth $472,617,000 after acquiring an additional 4,431,897 shares in the last quarter. Legal & General Group Plc grew its holdings in shares of Sabra Healthcare REIT by 16.5% in the fourth quarter. Legal & General Group Plc now owns 1,427,180 shares of the real estate investment trust’s stock valued at $27,031,000 after purchasing an additional 201,667 shares in the last quarter. UBS Group AG grew its holdings in shares of Sabra Healthcare REIT by 143.1% in the fourth quarter. UBS Group AG now owns 1,460,219 shares of the real estate investment trust’s stock valued at $27,657,000 after purchasing an additional 859,584 shares in the last quarter. Advisors Capital Management LLC increased its position in Sabra Healthcare REIT by 3.2% in the fourth quarter. Advisors Capital Management LLC now owns 2,382,935 shares of the real estate investment trust’s stock worth $45,133,000 after purchasing an additional 73,281 shares during the last quarter. Finally, Lasalle Investment Management Securities LLC bought a new stake in Sabra Healthcare REIT in the fourth quarter worth $66,938,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. Cantor Fitzgerald upped their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research note on Monday, May 11th. Scotiabank dropped their price objective on shares of Sabra Healthcare REIT from $22.00 to $19.00 and set a “sector perform” rating for the company in a research note on Thursday, June 18th. Citigroup downgraded shares of Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and reduced their target price for the stock from $24.00 to $19.00 in a report on Monday, June 22nd. Wall Street Zen upgraded shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. Finally, Weiss Ratings downgraded shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a report on Thursday, June 4th. Five research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $21.45.

Sabra Healthcare REIT Trading Down 1.3%

Shares of SBRA traded down $0.26 during mid-day trading on Friday, reaching $19.62. 2,267,446 shares of the company’s stock traded hands, compared to its average volume of 3,287,241. The stock has a market cap of $4.95 billion, a P/E ratio of 31.14, a P/E/G ratio of 1.46 and a beta of 0.65. The stock’s 50-day moving average is $19.67 and its two-hundred day moving average is $19.70. Sabra Healthcare REIT, Inc. has a 12 month low of $17.17 and a 12 month high of $21.28. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The firm had revenue of $211.74 million during the quarter, compared to analyst estimates of $209.20 million. During the same period last year, the company earned $0.37 EPS. Sabra Healthcare REIT’s quarterly revenue was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Research analysts forecast that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were paid a $0.30 dividend. The ex-dividend date was Friday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 6.1%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 190.48%.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.